Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial (Q44726799)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial |
scientific article |
Statements
1 reference
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial (English)
1 reference
Patrick W Serruys
1 reference
Marie-Claude Morice
1 reference
Alexandre Abizaid
1 reference
Andrea S Abizaid
1 reference
Egon Wuelfert
1 reference
Marco A Costa
1 reference
Didier Blanchard
1 reference
Mariano Albertal
1 reference
Hélèn Eltchaninoff
1 reference
Giulio Guagliumi
1 reference
Laarman Geert-Jan
1 reference
Amanda G M R Sousa
1 reference
Lindeboom Wietze
1 reference
J Eduardo Sousa
1 reference
Ravel Investigators
1 reference
1 January 2004
1 reference
1 reference
25
1 reference
2
1 reference
107-112
1 reference
Identifiers
1 reference
1 reference